Key details
Sponsor
Bar-Chama, Natan, M.D.
Enrollment target
~75 participants
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 50 Years
Last updated January 2024